arrow
K

Ken Herrmann

University of Duisburg-Essen
H指数:94
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

[177Lu]Lu-DOTA-TATE plus long-acting octreotide in patients with newly diagnosed, advanced, grade 2–3, gastroenteropancreatic neuroendocrine tumours: preplanned and post-hoc efficacy analyses from the randomised, phase 3 NETTER-2 trial

[177Lu]Lu-DOTA-TATE联合长效奥曲肽治疗新诊断的、进展期、2-3级胃肠胰腺神经内分泌肿瘤患者的疗效分析:来自随机III期NETTER-2试验的预先计划和事后分析

2026-08-070
OA
Diagnostic value of [68Ga]Ga-FAPI-46 PET in comparison to [18F]FDG PET in triple-negative breast cancer and potential for theranostic application

三阴性乳腺癌中[68Ga]Ga-FAPI-46 PET与[18F]FDG PET的比较诊断价值及其治疗诊断应用潜力

2026-08-030
OA
European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine

欧洲原发性儿童及成人骨肉瘤和尤因肉瘤影像学指南:FOSTER联盟、Euro Ewing联盟、欧洲儿科放射学会和欧洲核医学协会的系统综述与联合声明

2026-06-290
PRE
Reply to Armando Stabile, Giorgio Gandaglia, Arturo Chiti, and Francesco Montorsi’s Letter to the Editor re: Ken Herrmann, Jochen Walz, Steven MacLennan, et al. SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.005

回复Armando Stabile,Giorgio Gandaglia,Arturo Chiti和Francesco Montorsi给编辑的信re: Ken Herrmann,Jochen Walz,Steven MacLennan等。SPARC: 标准化前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描分析和报告共识: Delphi分析。Eur Urol.在新闻中。https://doi.org/10.1016/j.eururo.2025.08.005

2026-01-290
PRE
Clinical Impact of Changes in Tumor Uptake and Volume on PSMA PET/CT During [177Lu]Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer

转移性去势抵抗性前列腺癌在[177Lu]Lu-PSMA治疗期间,肿瘤摄取和体积变化对PSMA PET/CT的临床影响

2026-01-010
PRE
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer

盆腔罗塞塔分类项目:前列腺癌盆腔淋巴结图谱的跨学科建议

2026-01-010
PRE
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024

未来晚期前列腺癌临床研究的路线图:2024年晚期前列腺癌共识会议(APCCC)的研究结果

2025-11-210
PRE
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 68Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management

德国癌症研究中心(DKTK)多中心前瞻性Ⅰ/Ⅱ期68Ga-PSMA-11 PET成像试验:针对新诊断高危前列腺癌的安全性与诊断准确性(与组织病理学比较)及其对临床管理的影响

2025-11-150
OAAI
Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?

新诊断胶质母细胞瘤患者中骨髓毒性的分布及预后意义:是否应更积极治疗?

2025-11-010
OAAI
DISTRIBUTION AND PROGNOSTIC SIGNIFICANCE OF MYELOTOXICITY IN NEWLY DIAGNOSED GLIOBLASTOMA IN A REAL-LIFE COHORT: TIME TO TREAT MORE AGGRESSIVELY?

新诊断胶质母细胞瘤真实世界队列中骨髓毒性的分布及预后意义:是时候更积极治疗了吗?

2025-10-010
OAAI